title: Contribution of the latent transforming growth factor-β binding protein 2 gene to etiology of primary open angle glaucoma and pseudoexfoliation syndrome.
abstract: OBJECTIVE
  To assess for the first time the possible contribution of latent transforming growth factor (TGF)-beta binding protein 2 (LTBP2), an extracellular matrix (ECM) protein that associates with fibrillin-1-containing microfibrils, to the etiology of primary open angle glaucoma (POAG) and pseudoexfoliation (PEX) syndrome. Mutations in LTBP2 have previously been shown to be the cause of primary congenital glaucoma (PCG) and other disorders that often manifest as secondary glaucoma.
  
  
  METHODS
  All exons of LTBP2 were sequenced in the DNA of 42 unrelated patients with POAG and 48 unrelated patients with PEX syndrome. Contribution of candidate variations to disease was assessed by screening in control individuals and use of biochemical, bioinformatics, and evolutionary criteria, and in one case by segregation analysis within the family of a proband with POAG. Microscopy was performed on the skin of a patient with PEX syndrome whose condition developed into PEX glaucoma during the course of the study and on the skin of her son previously identified with PCG who harbored the same LTBP2 mutation.
  
  
  RESULTS
  Among the 30 sequence variations observed in LTBP2, five found in five patients with POAG and two found in two patients with PEX glaucoma syndrome may contribute to their diseases. One of the mutations was observed in a patient with POAG and in a patient with PEX glaucoma syndrome. Light, fluorescent, and electron microscopy showed that a mutation present in one of the individuals affected with PEX glaucoma syndrome and in her son affected with PCG causes disruptions in the ECM.
  
  
  CONCLUSIONS
  Some LTBP2 sequence variations can contribute to the etiology of POAG and PEX glaucoma syndrome. It is not expected that in these diseases LTBP2 mutations behave in a strictly Mendelian fashion with complete penetrance. In conjunction with recent findings, the results suggest that anomalies in the ECM are among the factors that can contribute to POAG and PEX glaucoma syndrome. LTBP2 and other related ECM protein coding genes should be screened in larger cohorts with these diseases, which are common disorders and important to the public health.
authors: School of Biology, University College of Science, University of Tehran, Tehran, Iran.
authors: Sahar
authors: S
authors: Jelodari-Mamaghani
authors: Ramona
authors: R
authors: Haji-Seyed-Javadi
authors: Fatemeh
authors: F
authors: Suri
authors: Naveed
authors: N
authors: Nilforushan
authors: Shahin
authors: S
authors: Yazdani
authors: Kambiz
authors: K
authors: Kamyab
authors: Elahe
authors: E
authors: Elahi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D015331:Cohort Studies; D004252:DNA Mutational Analysis; D017889:Exfoliation Syndrome / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D005109:Extracellular Matrix / Q000235:genetics / Q000473:pathology; D005260:Female; D014644:Genetic Variation; D005902:Glaucoma, Open-Angle / Q000209:etiology / Q000235:genetics* / Q000473:pathology; D006801:Humans; D053779:Latent TGF-beta Binding Proteins / Q000737:chemistry / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010375:Pedigree; D019683:Penetrance; D012867:Skin / Q000473:pathology; D013577:Syndrome; D055815:Young Adult
chemical_list: C509035:LTBP2 protein, human; D053779:Latent TGF-beta Binding Proteins
references: Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2796-801
references: 19182256
references: Biochem J. 2000 Dec 15;352 Pt 3:601-10
references: 11104663
references: Mol Vis. 2010 Apr 21;16:705-12
references: 20431720
references: Hum Genet. 2010 Oct;128(4):365-71
references: 20617341
references: Ophthalmology. 2009 Nov;116(11):2101-9
references: 19744731
references: Mol Vis. 2011;17:2570-9
references: 22025892
references: Nat Methods. 2010 Apr;7(4):248-9
references: 20354512
references: Mol Cell Biochem. 2003 Nov;253(1-2):223-31
references: 14619973
references: Nat Genet. 2011 Jun;43(6):579-84
references: 21532570
references: Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1459-63
references: 18385063
references: Exp Eye Res. 2001 Dec;73(6):765-80
references: 11846508
references: Am J Hum Genet. 2009 May;84(5):664-71
references: 19361779
references: J Biol Chem. 2009 Nov 13;284(46):31493-7
references: 19734141
references: Acta Paediatr Belg. 1980 Jan-Mar;33(1):57-61
references: 7405589
references: Am J Ophthalmol. 2006 May;141(5):921-937
references: 16678509
references: J Med Genet. 1994 Apr;31(4):338-9
references: 8071963
references: Eur J Hum Genet. 2010 Jul;18(7):761-7
references: 20179738
references: Mol Vis. 2008;14:2349-56
references: 19096718
references: Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3742-52
references: 16186358
references: Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3262-7
references: 16877390
references: Exp Eye Res. 2009 Apr;88(4):676-82
references: 19087875
references: Science. 1997 Jan 31;275(5300):668-70
references: 9005853
references: PLoS Genet. 2011 Feb;7(2):e1001306
references: 21379321
references: Am J Hum Genet. 2004 Jun;74(6):1314-20
references: 15108121
references: Science. 2007 Sep 7;317(5843):1397-400
references: 17690259
references: Mol Vis. 2008 Mar 13;14:508-17
references: 18385784
references: Eur J Hum Genet. 2011 Mar;19(3):326-33
references: 21081970
references: Invest Ophthalmol Vis Sci. 2006 Jan;47(1):226-34
references: 16384967
references: Hum Mutat. 2002 Sep;20(3):153-61
references: 12203987
references: Hum Mol Genet. 2009 Oct 15;18(20):3969-77
references: 19656777
references: Hum Mol Genet. 2000 Apr 12;9(7):1109-17
references: 10767336
references: Exp Eye Res. 2009 Apr;88(4):769-75
references: 19114037
references: Ophthalmology. 1998 Jun;105(6):951-68
references: 9627642
references: Nat Genet. 1996 Feb;12(2):209-11
references: 8563763
references: Exp Eye Res. 2006 Apr;82(4):545-57
references: 16386733
references: J Med Genet. 2000 Jan;37(1):9-25
references: 10633129
references: Nat Genet. 2004 Feb;36(2):178-82
references: 14745449
references: Surv Ophthalmol. 2001 Jan-Feb;45(4):265-315
references: 11166342
references: Humangenetik. 1973;20(2):187-9
references: 4785169
references: Mol Cell Biol. 1995 Dec;15(12):6932-42
references: 8524260
references: Hum Mutat. 2012 Aug;33(8):1182-7
references: 22539340
references: Clin Biochem. 2006 Mar;39(3):249-58
references: 16332362